Bionik Laboratories Corp. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q1 2020 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary: Bionik Laboratories Corp. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q1 2020 to Q1 2023.
Bionik Laboratories Corp. Contract with Customer, Liability, Noncurrent for the quarter ending March 31, 2023 was $303K, a 18.2% increase year-over-year.

Contract with Customer, Liability, Noncurrent, Quarterly (USD)

Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$303K	+$46.6K	+18.2%	Mar 31, 2023	10-K	2023-06-21
Q4 2022	$274K	+$5.28K	+1.97%	Dec 31, 2022	10-Q	2023-02-08
Q3 2022	$258K	-$21.6K	-7.71%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$211K	-$108K	-33.8%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$257K	-$47.3K	-15.6%	Mar 31, 2022	10-K	2023-06-21
Q4 2021	$268K	-$43.1K	-13.8%	Dec 31, 2021	10-Q	2022-02-09
Q3 2021	$280K			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$319K			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$304K	-$112K	-26.9%	Mar 31, 2021	10-K	2022-06-09
Q4 2020	$311K			Dec 31, 2020	10-Q	2021-02-11
Q1 2020	$416K			Mar 31, 2020	10-K	2021-06-24

Showing 1 to 11 of 11 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.